SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-22-006659
Filing Date
2022-05-13
Accepted
2022-05-13 09:06:47
Documents
62
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q edsa_10q.htm   iXBRL 10-Q 761984
2 AMENDMENT TO EMPLOYMENT AGREEMENT edsa_ex101.htm EX-10.1 12505
3 AMENDMENT TO EMPLOYMENT AGREEMENT edsa_ex102.htm EX-10.2 12351
4 AMENDMENT TO EMPLOYMENT AGREEMENT edsa_ex103.htm EX-10.3 12485
5 CERTIFICATION edsa_ex311.htm EX-31.1 10710
6 CERTIFICATION edsa_ex312.htm EX-31.2 10668
7 CERTIFICATION edsa_ex321.htm EX-32.1 3905
8 CERTIFICATION edsa_ex322.htm EX-32.2 3965
  Complete submission text file 0001654954-22-006659.txt   3633695

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA edsa-20220331.xsd EX-101.SCH 44022
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE edsa-20220331_lab.xml EX-101.LAB 234564
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE edsa-20220331_cal.xml EX-101.CAL 39498
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edsa-20220331_pre.xml EX-101.PRE 187095
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE edsa-20220331_def.xml EX-101.DEF 87207
56 EXTRACTED XBRL INSTANCE DOCUMENT edsa_10q_htm.xml XML 551568
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37619 | Film No.: 22920484
SIC: 2834 Pharmaceutical Preparations